Skip to main content
Clinical Trials/CTRI/2017/05/008552
CTRI/2017/05/008552
Recruiting
Phase 2

An open label single arm clinical study on the effectiveness of agastya ghrita pana and tarpana in the management of shleshmavidagdha drishti(retinitis pigmentosa).

Sri Dharmasthala Manjunatheshwara College of Ayurveda and Hospital0 sites30 target enrollmentTBD

Overview

Phase
Phase 2
Intervention
Not specified
Conditions
Health Condition 1: null- Shleshma vidagdha Drishti( Retinitis pigmentosa)
Sponsor
Sri Dharmasthala Manjunatheshwara College of Ayurveda and Hospital
Enrollment
30
Status
Recruiting
Last Updated
4 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
4 years ago
Study Type
Interventional

Investigators

Sponsor
Sri Dharmasthala Manjunatheshwara College of Ayurveda and Hospital

Eligibility Criteria

Inclusion Criteria

  • 1\. Patient ready to sign in informed consent form irrespective of sex, and religion. Naktandhata (night blindness)
  • 2\. Difficulty in dark adaptation
  • 3\. Reduced field of vision
  • 4\.Blurredness of vision
  • 5\.Visual acuity test revealing reduced visual acuity.
  • 6\.Perimetry showing peripheral visual field defect
  • 7\. Opthalamoscopic evaluation of Fundus revealing classical triad of Retinitis pigmentosa (arteriolar attenuation, retinal bone\-spicule pigmentation and waxy pallor).
  • 8\. Pictorial assessment of Retinitis pigmentosa through Fundal photograph

Exclusion Criteria

  • 1\.Patients having total blindness.
  • 2\.Patient with all kind of diabetic retinopathy and diabetic maculopathy.
  • 3\.Patient with pregnancy and lactating period

Outcomes

Primary Outcomes

Not specified

Similar Trials